dacarbazine and Leukemia, Myeloid

dacarbazine has been researched along with Leukemia, Myeloid in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amadori, S; Bonmassar, E; Bonmassar, L; Buccisano, F; Cantonetti, M; Caporaso, P; D'Atri, S; Turriziani, M; Venditti, A	1
Alibhai, SM; Brandwein, JM; Gupta, V; Minden, MD; Schimmer, AD; Schuh, AC; Wells, RA; Xu, W; Yang, L	1
Tear, S	1
Grebe, G; Lira, P	1
Rosenberg, SA	1

Trials

1 trial(s) available for dacarbazine and Leukemia, Myeloid

Article	Year
A phase II study of temozolomide therapy for poor-risk patients aged >or=60 years with acute myeloid leukemia: low levels of MGMT predict for response. Leukemia, 2007, Volume: 21, Issue:4 Topics: Acute Disease; Aged; Antineoplastic Agents; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Leukemia, Myeloid; Middle Aged; Predictive Value of Tests; Temozolomide; Tumor Suppressor Proteins	2007

Article

Year

A phase II study of temozolomide therapy for poor-risk patients aged >or=60 years with acute myeloid leukemia: low levels of MGMT predict for response.

Leukemia, 2007, Volume: 21, Issue:4

Topics: Acute Disease; Aged; Antineoplastic Agents; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Leukemia, Myeloid; Middle Aged; Predictive Value of Tests; Temozolomide; Tumor Suppressor Proteins

2007

Other Studies

4 other study(ies) available for dacarbazine and Leukemia, Myeloid

Article	Year
O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro. Pharmacological research, 2006, Volume: 53, Issue:4 Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Synergism; Guanine; HL-60 Cells; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Tumor Cells, Cultured	2006
American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Clinical Trials, Phase I as Topic; Dacarbazine; Hematologic Neoplasms; Hematology; Humans; Hydrazines; Leukemia, Myeloid; Multiple Myeloma; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-kit; Sulfonamides; Temozolomide	2007
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy]. Revista medica de Chile, 1984, Volume: 112, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubicin; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Thioguanine; Vinblastine; Vincristine	1984
Future prospects for immunotherapy. Cancer, 1975, Volume: 36, Issue:2 Topics: Animals; BCG Vaccine; Carcinoma, Hepatocellular; Dacarbazine; Guinea Pigs; Humans; Immunotherapy; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Neoplasms; Melanoma; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Sarcoma	1975